[Comparative evaluation of treatment results of melanoblastoma of the limbs with or without perfusion chemotherapy].
The clinical picture and long-term results of the treatment of 123 patients with melanoblastoma of the limbs have been studied. 39 patients were subjected only to the surgical treatment, 84 patients with a developed tumor process were subjected to the combined treatment -- surgery with perfusional chemotherapy. 3 years survival has proved to be similar in both groups; (70.0% and 72.9%); 5 years survival has been 10% higher in the group subjected to the combined treatment (54.5% and 64.0%).
D000328:Adult; D000368:Aged; D010478:Chemotherapy, Cancer, Regional Perfusion; D005121:Extremities / Q000601:surgery; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000601:surgery; D008558:Melphalan / Q000008:administration & dosage* / Q000627:therapeutic use; D008875:Middle Aged; D013852:Thiotepa / Q000008:administration & dosage* / Q000627:therapeutic use
D013852:Thiotepa; D008558:Melphalan
Sravnitel'naia otsenka rezul'tatov lecheniia melanoblastom konechnosteĭ s ispol'zovaniem perfuzionnoĭ khimioterapii i bez nee.